Athens Research/Cambio - Excellence in Molecular Biology/8 prep sample (max 1 per customer)/GA-322-108

价格
面议
货号:GA-322-108
浏览量:58
品牌:Athens Research
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Extraction & Purification - RNA

Extraction & Purification - RNA: Tissue/Cultures

RNA Isolation from tissues and cell cultures
  • Catalogue
  • Description
  • References

Ribospin™ vRD II

Ribospin™ vRD II provides a convenient method for isolation of RNA and DNA from cell-free fluid, cell-cultrue supernatant, plasma, serum, swab, urine, and virusinfected samples.Ribospin TM vRD II procedures employed the glassfiber membrane technology for the fastest and the most convenient of high purity RNA and DNA isolation, instead of conventional alcoholrecipitation or phenol/chloroform extraction. Ribospin™ vRD II buffer system provides the effective binding condition of RNA and DNA to glassfiber membrane and the impurities on the membrane are washed away by two different wash buffers. At last, pure RNA and DNA are eluted by nuclease-free water. Whole procedure takes only 15 minutes and the purified nucleic acid is suitable for PCR, RT-PCR, or any downstream application without further manipulation...

GeneAll

Catalogue No.DescriptionPack SizePriceQty
  • Change to:
  • €
GA-322-108GeneAll Ribospin vRD II8 prep sample (max 1 per customer)£0.00QuantityAdd to Order
GA-322-150GeneAll Ribospin vRD II50 mini preps£146.00QuantityAdd to Order
GA-322-901Buffer NVL16 ml£19.60QuantityAdd to Order

Ribospin™ vRD II

Ribospin™ vRD II provides a convenient method for isolation of RNA and DNA from cell-free fluid, cell-cultrue supernatant, plasma, serum, swab, urine, and virusinfected samples.Ribospin TM vRD II procedures employed the glassfiber membrane technology for the fastest and the most convenient of high purity RNA and DNA isolation, instead of conventional alcoholrecipitation or phenol/chloroform extraction. Ribospin™ vRD II buffer system provides the effective binding condition of RNA and DNA to glassfiber membrane and the impurities on the membrane are washed away by two different wash buffers. At last, pure RNA and DNA are eluted by nuclease-free water. Whole procedure takes only 15 minutes and the purified nucleic acid is suitable for PCR, RT-PCR, or any downstream application without further manipulation...

GeneAll

For Research Use Only

Features and Benefits

- Spin column format- Stable and consistent yield- Preparation time : ~ 15 minutes- No phenol / chloroform extraction- No ethanol precipitation- Micro column & carrier RNA enhance the performance of viral sample extraction- Various viral samples : cell-free fluid, cell-culture supernatant,plasma, serum, swab, urine and virus-infected samples- Ready for use in PCR, RT-PCR, real-time PCR and other analyticalprocedures

Description

RibospinTM vRD II provides a convenient method for isolation of RNA and DNA from cell-free fluid, cell-cultrue supernatant, plasma, serum, swab, urine, and virusinfected samples.Ribospin TM vRD II procedures employed the glassfiber membrane technology for the fastest and the most convenient of high purity RNA and DNA isolation, instead of conventional alcohol recipitation or phenol/chloroform extraction. Ribospin TM vRD II buffer system provides the effective binding condition of RNA and DNA to glassfiber membrane and the impurities on the membrane are washed away by two different wash buffers. At last, pure RNA and DNA are eluted by nuclease-free water. Whole procedure takes only 15 minutes and the purified nucleic acid is suitable for PCR, RT-PCR, or any downstream application without further manipulation.Ribospin TM vRD II procedure should be performed at room temperature. The purified nucleic acid should be treated with care because RNA is very sensitive to contaminants, such as RNases, often found on general labware and dust. To ensure RNA-stability, it is recommended to store at 4 °C for immediate analysis or to freeze at -70 °C for long-term storage.

Click here for our latest application note

Procedure

Specification

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Ribospin™ vRD II

Ribospin™ vRD II provides a convenient method for isolation of RNA and DNA from cell-free fluid, cell-cultrue supernatant, plasma, serum, swab, urine, and virusinfected samples.Ribospin TM vRD II procedures employed the glassfiber membrane technology for the fastest and the most convenient of high purity RNA and DNA isolation, instead of conventional alcoholrecipitation or phenol/chloroform extraction. Ribospin™ vRD II buffer system provides the effective binding condition of RNA and DNA to glassfiber membrane and the impurities on the membrane are washed away by two different wash buffers. At last, pure RNA and DNA are eluted by nuclease-free water. Whole procedure takes only 15 minutes and the purified nucleic acid is suitable for PCR, RT-PCR, or any downstream application without further manipulation...

GeneAll

List of references here

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Myeloperoxidase Enzyme Immunoassay Kit 髓过氧化物酶 免疫分析试剂盒 Human MPO EIA KIT FEATURES: USE - Measure human MPO in a variety of matrices SAMPLE -Serum, Platelet-Poor Heparin Plasma, Saliva, Urine or Tissue Culture Media SAMPLES / KIT - 40 in duplicate SENSITIVITY - 0.068 ng/mL STABILITY - liquid reagents stable at 4°C QUICK RESULTS - 2.5 HOURS Myeloperoxidase (MPO) is a tetrameric heme-containing protein abundantly produced in neutrophil granulocytes where it plays an important anti-microbial role. During degranulation MPO is released into the extracellular space. There, as part of the neutrophils “respiratory burst”, it produces hypochlorous acid from hydrogen peroxide and Cl–. MPO also uses hydrogen peroxide to oxidize tyrosine to the tyrosyl radical. Both hypochlorous acid and tyrosyl are cytotoxic and when present can kill bacteria and other pathogens. Hereditary deficiency of myeloperoxidase predisposes individuals to immune deficiency. Studies have shown an association between elevated MPO levels and coronary artery disease, and in 2003 it was suggested that MPO may serve as a sensitive predictor of myocardial infarction in patients complaining of chest pain. Since that time the clinical utility of MPO testing in cardiac patients has been solidly established in the literature with well over 100 papers published. In 2010 this clinical application was further refined by additional studies which determined that measuring both MPO and C-reactive protein (CRP) provided more accurate prediction of mortality risk than measuring just CRP alone.